https://scholars.lib.ntu.edu.tw/handle/123456789/527839
標題: | The diagnosis and classification of autoimmune coagulopathy: An updated review | 作者: | HSIU-HAO CHANG BOR-LUEN CHIANG |
公開日期: | 2014 | 出版社: | Elsevier | 卷: | 13 | 期: | 4月5日 | 起(迄)頁: | 587-590 | 來源出版物: | Autoimmunity reviews | 摘要: | Autoantibodies against coagulation factors can develop in patients associated with autoimmune disorders, malignancies, pregnancy, and drug-induced or dermatological diseases. These antibodies can bind to functional epitopes of individual coagulation factors, neutralize their activity or promote their clearance, and clinically leading to bleeding conditions. Among them, the most common one is that directed against factor VIII (FVIII). Patients with autoantibodies against FVIII often have severe hemorrhage and delayed diagnosis can contribute to high mortality in these patients. Further, autoantibodies against other coagulation factors, such as Factors V, XI, XII, XIII, and the vitamin-K dependent proteins, occur more rarely. The pathogenesis for developing autoantibodies against these coagulation factors is still unclear. A mechanism of breakdown in immune tolerance, which may be derived from a combination of genetic and environmental factors as well as the aging of the immune system in elderly individuals, may be responsible for the development of autoantibodies against FVIII. In this article, we reviewed and updated the classification and diagnostic algorithms for identifications of autoantibodies against the coagulation factors in clotting cascade. ? 2014 Elsevier B.V. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84896317302&doi=10.1016%2fj.autrev.2014.01.032&partnerID=40&md5=5f6e98c6ca9c3f33632f6066bbd86058 https://scholars.lib.ntu.edu.tw/handle/123456789/527839 |
ISSN: | 1568-9972 | DOI: | 10.1016/j.autrev.2014.01.032 | SDG/關鍵字: | activated prothrombin complex; autoantibody; blood clotting factor; blood clotting factor 10; blood clotting factor 11; blood clotting factor 12; blood clotting factor 13; blood clotting factor 5; blood clotting factor 7; blood clotting factor 8; blood clotting factor 8 antibody; blood clotting factor 9; corticosteroid; cyclophosphamide; desmopressin; fibrinogen; immunoglobulin A; immunoglobulin G; immunoglobulin G1; immunoglobulin G4; immunoglobulin M; immunosuppressive agent; prothrombin; rituximab; vitamin K group; aging; autoimmune coagulopathy; autoimmune disease; bleeding; blood clotting disorder; clinical feature; delayed diagnosis; disease classification; environmental factor; hemophilia A; human; immune system; immunoadsorption; immunological tolerance; immunosuppressive treatment; mortality; pathogenesis; plasmapheresis; review; Acquired hemophilia; Acquired inhibitor; Autoantibodies; Autoimmune coagulopathy; Autoantibodies; Autoimmune Diseases; Blood Coagulation Disorders; Blood Coagulation Factors; Humans; Immune Tolerance; Signal Transduction |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。